An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility …
C Mukuria, D Rowen, S Harnan, A Rawdin… - … health economics and …, 2019 - Springer
Background Mapping is an increasingly common method used to predict instrument-specific
preference-based health-state utility values (HSUVs) from data obtained from another health …
preference-based health-state utility values (HSUVs) from data obtained from another health …
'Mapping'health state utility values from non-preference-based measures: a systematic literature review in rare diseases
M Meregaglia, A Whittal, E Nicod, M Drummond - Pharmacoeconomics, 2020 - Springer
Background The use of patient-reported outcome measures (PROMs) to monitor the effects
of disease and treatment on patient symptomatology and daily life is increasing in rare …
of disease and treatment on patient symptomatology and daily life is increasing in rare …
[HTML][HTML] Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
I Roberts, H Shakur-Still, A Aeron-Thomas… - Health Technology …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Tranexamic acid safely reduces mortality in traumatic extracranial bleeding.
Intracranial bleeding is common after traumatic brain injury and can cause brain herniation …
Intracranial bleeding is common after traumatic brain injury and can cause brain herniation …
Utility-weighted modified Rankin scale as primary outcome in stroke trials: a simulation study
SA Dijkland, DC Voormolen, E Venema… - Stroke, 2018 - Am Heart Assoc
Background and Purpose—The utility-weighted modified Rankin Scale (UW-mRS) has been
proposed as a new patient-centered primary outcome in stroke trials. We aimed to describe …
proposed as a new patient-centered primary outcome in stroke trials. We aimed to describe …
Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
LA Gray, M Hernandez Alava, AJ Wailoo - BMC cancer, 2021 - Springer
Background The types of outcomes measured collected in clinical studies and those
required for cost-effectiveness analysis often differ. Decision makers routinely use quality …
required for cost-effectiveness analysis often differ. Decision makers routinely use quality …
Development and use of a content search strategy for retrieving studies on patients' views and preferences
A Selva, I Solà, Y Zhang, H Pardo-Hernandez… - Health and quality of life …, 2017 - Springer
Background Identifying scientific literature addressing patients' views and preferences is
complex due to the wide range of studies that can be informative and the poor indexing of …
complex due to the wide range of studies that can be informative and the poor indexing of …
[HTML][HTML] Development of methods for the mapping of utilities using mixture models: mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in patients with asthma
LA Gray, MH Alava, AJ Wailoo - Value in Health, 2018 - Elsevier
Background Studies have shown that methods based on mixture models work well when
mapping clinical to preference-based methods. Objectives To develop these methods in …
mapping clinical to preference-based methods. Objectives To develop these methods in …
[HTML][HTML] Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
MH Alava, A Wailoo, S Pudney, L Gray… - Health Technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Cost-effectiveness analysis using quality-adjusted life-years as the
measure of health benefit is commonly used to aid decision-makers. Clinical studies often …
measure of health benefit is commonly used to aid decision-makers. Clinical studies often …
[HTML][HTML] Correlation between the levels of NLRP3, Hcy, IL-1β, IL-18 and the prognosis in patients with hemorrhagic stroke
Q Li, Z Zhao, K Si, J Zhou, H Liu, R Lin - American Journal of …, 2021 - ncbi.nlm.nih.gov
Objective: To explore the connection of nucleotide-binding oligomerization domain-like
receptors 3 (NLRP3), homocysteine (Hcy), interleukin-1β (IL-1β), interleukin-18 (IL-18) in …
receptors 3 (NLRP3), homocysteine (Hcy), interleukin-1β (IL-1β), interleukin-18 (IL-18) in …
[HTML][HTML] Mapping the FACT-B instrument to EQ-5D-3L in patients with breast cancer using adjusted limited dependent variable mixture models versus response …
LA Gray, AJ Wailoo, MH Alava - Value in Health, 2018 - Elsevier
Background Preference-based measures of health, such as the three-level EuroQol five-
dimensional questionnaire (EQ-5D-3L), are required to calculate quality-adjusted life-years …
dimensional questionnaire (EQ-5D-3L), are required to calculate quality-adjusted life-years …